<code id='BB8BCF4C45'></code><style id='BB8BCF4C45'></style>
    • <acronym id='BB8BCF4C45'></acronym>
      <center id='BB8BCF4C45'><center id='BB8BCF4C45'><tfoot id='BB8BCF4C45'></tfoot></center><abbr id='BB8BCF4C45'><dir id='BB8BCF4C45'><tfoot id='BB8BCF4C45'></tfoot><noframes id='BB8BCF4C45'>

    • <optgroup id='BB8BCF4C45'><strike id='BB8BCF4C45'><sup id='BB8BCF4C45'></sup></strike><code id='BB8BCF4C45'></code></optgroup>
        1. <b id='BB8BCF4C45'><label id='BB8BCF4C45'><select id='BB8BCF4C45'><dt id='BB8BCF4C45'><span id='BB8BCF4C45'></span></dt></select></label></b><u id='BB8BCF4C45'></u>
          <i id='BB8BCF4C45'><strike id='BB8BCF4C45'><tt id='BB8BCF4C45'><pre id='BB8BCF4C45'></pre></tt></strike></i>

          Home / comprehensive / hotspot

          hotspot


          hotspot

          author:entertainment    Page View:28149
          Adam's take main illustration
          Molly Ferguson/STAT

          Biotech is awash in PIPEs.

          The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.

          advertisement

          Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In